Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open Label Investigation of the Tolerability and Pharmacokinetics of Oral Cysteamine in Adults With Cystic Fibrosis.

NCT02212431 is registered in ClinicalTrials.gov with University of Aberdeen as lead sponsor.

NCT NCT02212431
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02212431 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open Label Investigation of the Tolerability and Pharmacokinetics of Oral Cysteamine in Adults With Cystic Fibrosis.
Lead sponsor
University of Aberdeen
Phase
Phase 1/2
Overall status
Completed
Start date
August 31, 2014
Completion date
April 30, 2015
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cystic fibrosis